Spironolactone Tablet, Film Coated
Product Images NDC 31722-096

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 31722-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone100mg100scount (Spironolactone100mg100scount)

Label for Spironolactone Tablets, USP 100 mg by Camber Pharmaceuticals, Inc. The label indicates a quantity of 100 film-coated tablets for oral use. Storage instructions specify keeping at controlled room temperature and protecting from light. Manufacturer details include Annora Pharma Pvt. Ltd., India.*

FDA Label Image

Spironolactone25mg100scount (Spironolactone25mg100scount)

The label for Spironolactone Tablets USP, 25 mg film-coated oral tablets, containing 100 tablets per container. The label displays the Camber Pharmaceuticals, Inc. logo, national drug code (NDC) 31722-094-01, storage instructions, dispensing cautions, and contact information for Camber Pharmaceuticals. It indicates prescription use only and mentions manufacturing by Annora Pharma Pvt. Ltd.*

FDA Label Image

Spironolactone50mg100scount (Spironolactone50mg100scount)

Label for spironolactone tablets, USP, 50 mg strength, film-coated, oral dosage form. The label indicates a package size of 100 tablets and the product is for prescription use only. Manufactured by Annora Pharma Pvt. Ltd. for Camber Pharmaceuticals, Inc., with storage and usage instructions included. A barcode and contact number are also present.*

FDA Label Image

Spironolactonecamberlogo (Spironolactonecamberlogo)

FDA Label Image

Spironolactonechemicalstructure (Spironolactonechemicalstructure)

Chemical structure diagram of spironolactone, displaying the molecular arrangement and bonding of the active ingredient spironolactone.*

FDA Label Image

Spironolactonefigure1 (Spironolactonefigure1)

A Kaplan-Meier survival curve comparing the probability of an event over months for spironolactone (n=822) versus placebo (n=841). The graph shows higher survival probability over time for spironolactone compared to placebo, with a log-rank p-value of less than 0.001 indicating statistical significance.*

FDA Label Image

Spironolactonefigure2 (Spironolactonefigure2)

A forest plot figure displaying hazard ratios (HR) and 95% confidence intervals for various subgroups in a study comparing spironolactone and placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and use of digoxin, ACE inhibitors, and beta blockers. The plot visually contrasts effectiveness with HR values less than 1 favoring spironolactone and values greater than 1 favoring placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.